NCT02578017View on ClinicalTrials.gov

ElectroNic Hydroxyurea AdhereNCE: A Strategy to Improve Hydroxyurea Adherence in Patients With Sickle Cell Disease

NACompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions
Sickle Cell Disease
Interventions
BEHAVIORAL

Mobile DOT

Mobile DOT is a multi-dimensional tool that uses automated reminders, adherence feedback messages, incentives, and video observation of medication administration.

Trial Locations (1)

43205

Nationwide Children's Hospital, Columbus

All Listed Sponsors
lead

Nationwide Children's Hospital

OTHER

NCT02578017 - ElectroNic Hydroxyurea AdhereNCE: A Strategy to Improve Hydroxyurea Adherence in Patients With Sickle Cell Disease | Biotech Hunter | Biotech Hunter